Comparative effects of rifabutin and rifampicin on hepatic microsomal enzyme activity in normal subjects

European Journal of Clinical Pharmacology

Volumn 34, Issue 6, 1988, Pages 595-599

  Perucca, E ^a   Grimaldi, R ^a   Frigo, G M ^a   Sardi, A ^b   Monig H ^c   Ohnhaus, E E ^c  

^a UNIVERSITY OF PAVIA   (Italy)

^b Nerviano Medical Sciences   (Italy)

^c UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

Author keywords

antimicrobial agent; healthy volunteers; microsomal enzyme induction; rifabutin; rifampicin

Indexed keywords

6BETA HYDROXYHYDROCORTISONE; CYTOCHROME P450; GAMMA GLUTAMYLTRANSFERASE; PHENAZONE; RIFABUTIN; RIFAMPICIN;

ADULT; DRUG METABOLISM; ENZYME INDUCTION; FEMALE; HUMAN; HUMAN EXPERIMENT; LIVER MICROSOME METABOLISM; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; ANTIPYRINE; COMPARATIVE STUDY; ENZYME INDUCTION; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HALF-LIFE; HUMAN; HYDROCORTISONE; MALE; METABOLIC CLEARANCE RATE; MICROSOMES, LIVER; RIFABUTIN; RIFAMPIN; RIFAMYCINS;

EID: 0023677409     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/BF00615223     Document Type: Article

References (25)

1. The two period cross-over trial
2. The effect of rifampicin on norethisterone pharmacokinetics
3. Effect of rifampicin treatment on the metabolism of oestradiol and 17-ethynyloes-tradiol by human liver microsomes
4. Influence of rifampicin on drug metabolism: differences between hexobarbital and antipyrine
5. Rifampicin and vitamin D metabolism
6. Studies on the different metabolic pathways of antipyrine in rats: influence of phenobarbital and 3-methylcholanthrene treatment
7. LM 427, a new spiropiperidyl rifamycin: in vitro and in vivo studies
8. Rapid and sensitive method for the determination of antipyrine in biological fluids by high pressure liquid chromatography
9. HPLC determination of antipyrine metabolites
10. Activity of ansamycin against Mycobacterium leprae in mice
11. Determination of in vitro susceptibility of Mycobacteria to ansamycin
12. Measurement of urinary 6-β-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of microsomal enzyme inducing capacity of antipyrine, phenobarbitone and rifampicin
13. Effect of enzyme induction on plasma lipids using antipyrine, phenobarbitone and rifampicin
14. A direct radioimmunoassay for 6-β-hydroxycortisol in human urine
15. Clinical consequences of microsomal enzyme induction by antiepileptic drugs
16. Quantitative determination by HPLC of urinary 6-β-hydroxycortisol, an indicator of enzyme induction by rifampicin and antiepileptic drugs
17. Urinary 17-hydroxycorticosteroid determination with p-hydrazinobenzensulfonic acid phosphoric acid
18. A kinetic photometric method for serum gamma-gamma-glutamyl-transpeptidase
19. Rifampicin and drug metabolism
20. Influence of 9-hydroxyellipticine and 3-methyl-cholanthrene treatment on in vivo antipyrine metabolite formation in rats
21. Influence of rifampicin treatment on antipyrine clearance and metabolite formation in patients with tuberculosis
22. Differential induction of antipyrine metabolism by rifampicin
23. In vitro susceptibility of Mycobacterium Avium Complex and Mycobacterium tubercolosis strains to a spiropiperidyl rifamycin
24. Induction of drug metabolism in man after rifampicin treatment measured by increased hexobarbital and tolbutamide clearance
25. Pharmacokinetic interactions with rifampicin